Outcomes of COVID-19 in Patients with Skin Cancer. 

 -  2021 
<br/><br/> The effect of skin cancer diagnosis on the risk of adverse outcomes from COVID-19 remains unknown. Few studies have shown cancer patients with COVID-19 have higher rates of mortality and hospitalizations compared to those without cancer, perhaps due to a combination of delayed diagnosis and pre-existing comorbidities from chemotherapy and radiation treatments.1. Copyright This article is protected by copyright. All rights reserved. 
<br/><br/><br/>English 
<br/><br/><label>ISSN: </label>0007-0963 
<br/><br/><label>Standard No.: </label>10.1111/bjd.20386 [doi] 
<br/><br/><label>Subjects--Topical Terms: </label><br/>*COVID-19<br/>*Skin Neoplasms<br/>Humans<br/>Risk Factors<br/>SARS-CoV-2
<br/><br/><label>Subjects--Geographic Terms: </label><br/>MedStar Washington Hospital Center
<br/><br/><label>Index Terms--Occupation: </label><br/>Dermatology<br/>Dermatology Residency
<br/><br/><label>Index Terms--Function: </label><br/>Letter